Government of CanadaPublic Health Agency of Canada / Agence de santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
   

 

Measuring Up

 

 

  

Public Health Agency of Canada (PHAC)

Measuring Up
A Health Surveillance Update on Canadian Children and Youth


Future Developments

Enhanced Surveillance of Women's Pregnancy Experiences

The Canadian Perinatal Surveillance System (CPSS), managed by the Bureau of Reproductive and Child Health in LCDC, is a national program that monitors trends and patterns in the health of pregnant women, mothers and infants in Canada. The CPSS Steering Committee and Bureau staff have identified a set of perinatal health indicators required for comprehensive national perinatal health surveillance. These include indicators of women's perspectives, experiences and health behaviours in pregnancy, childbirth and new motherhood. The currently available national health databases do not contain the data necessary for monitoring issues such as physical abuse of pregnant women, illicit drug use during pregnancy, breastfeeding duration (to 4 months and 6 months), postpartum depression and client satisfaction with services. Therefore, the CPSS will initiate a national reproductive health survey that will provide these data and enable the program to report on these very important aspects of maternal and infant health.

 

  1. Bureau of Reproductive and Child Health, LCDC. Analysis and interpretation of Statistics Canada data. 1999.

  2. Sachs BP, Fretts RC, Gardner R, Hellerstein S, Wampler NS, Wise PH. The impact of extreme prematurity and congenital anomalies on the interpretation of international comparisons of infant mortality. Obstet and Gynaecol 1995;85:941-46.

  3. Howell EM, Blondel B. International infant mortality rates: bias from reporting differences. Am J Public Health 1994;84:850-52.

  4. Joseph KS, Kramer MS. Recent trends in Canadian infant mortality rates: effect of changes in registration of live newborns weighing less than 500g. Can Med Assoc J 1996;155:1047-52.

  5. Joseph KS, Kramer MS. Canadian infant mortality: 1994 update [letter]. Can Med Assoc J 1997;156:161-63.

  6. OECD health data 98: a comparative analysis of 29 countries. France, 1998.

  7. Kramer MS, Platt R, Yang H, Joseph KS, Wen SW, Morin, L, Usher RH. Secular trends in preterm birth. A hospital-based cohort study. JAMA 1998;1849-54.

  8. Moutquin JM, Papiernik E. Can we lower the rate of preterm birth? Bull SOGC 1990; September:19-20.

  9. Joseph KS, Kramer MS, Marcoux S et al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med 1998;339:1434-39.

  10. Ventura SJ, Martin JA, Curtin SC, Mathews TJ. Report of final natality statistics, 1996. Monthly vital statistics report; vol 46 no 11, supp. Hyattsville, Maryland: National Center for Health Statistics. 1998.

  11. Day P, Lancaster P, Huang J. Australia's mothers and babies 1995. Perinatal Statistics Series 1998;6:76.

  12. Berkowitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 1993;15:414-43.

  13. Peacock JL, Bland JM, Anderson HR. Preterm delivery: effects of socioeconomic factors, psychological stress, smoking, alcohol and caffeine. BMJ 1995;311:531-6.

  14. Premature mortality due to congenital anomalies - United States. MMWR 1988;37:505.

  15. Elwood M, Elwood H, Little J. Classification, anatomy and embryology. In: Elwood M, Elwood H, Little J. Epidemiology and control of neural tube defects. Oxford: Oxford University Press, 1992.

  16. Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-35.

  17. Bureau of Reproductive and Child Health, LCDC. Analysis and interpretation of data from the Canadian Congenital Anomaly Surveillance System. 1999.

  18. Wald N, Cuckle H. Antenatal screening and diagnosis. In: Elwood M, Elwood H, Little J. Epidemiology and control of neural tube defects. Oxford: Oxford University Press, 1992.

  19. Gaull GE, Testa CA, Thomas PR, Weinreich DA. Fortification of the food supply with folic acid to prevent neural tube defects is not yet warranted. Nutrition 1996;126:773S-80S.

  20. International Centre for Birth Defects. International clearinghouse for birth defects monitoring systems: annual report 1998. Rome, Italy, 1998.

 

[Table of Contents] [Previous] [Next]

Last Updated: 1999-06-16 Top
Important Notices